TP53 and psoriasis: In comparison with MSCs obtained from healthy individuals, the authors demonstrated that the glycolysis levels were increased in MSCs obtained from psoriasis patients and this increase was related to miR-155 expression through the negative regulation of the TP53INP1/p53 signaling pathway.